From Casetext: Smarter Legal Research

Ivory v. Bayer Corporation

United States District Court, N.D. Mississippi, Eastern Division
Jan 28, 2010
CIVIL ACTION NO.: 1:10CV3-SA-JAD (N.D. Miss. Jan. 28, 2010)

Opinion

CIVIL ACTION NO.: 1:10CV3-SA-JAD.

January 28, 2010


ORDER GRANTING UNOPPOSED MOTION TO STAY PROCEEDINGS PENDING TRANSFER TO MDL-2100


Presently before the Court is the unopposed motion of Defendants Bayer Corporation, Bayer HealthCare Pharmaceuticals, Inc., and Bayer HealthCare, LLC, to stay the proceedings and to terminate all deadlines in this action.

The Court finds this motion is well taken. It is ORDERED that all proceedings in this action, including but not limited to any case management deadlines and any Rule 26 disclosure obligations, are hereby STAYED pending transfer of this action to MDL-2100, established in the United States District Court for the Southern District of Illinois and titled In re Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation. All pending dates and deadlines are hereby terminated.

SO ORDERED.


Summaries of

Ivory v. Bayer Corporation

United States District Court, N.D. Mississippi, Eastern Division
Jan 28, 2010
CIVIL ACTION NO.: 1:10CV3-SA-JAD (N.D. Miss. Jan. 28, 2010)
Case details for

Ivory v. Bayer Corporation

Case Details

Full title:LETHA R. IVORY PLAINTIFF v. BAYER CORPORATION, BAYER HEALTHCARE…

Court:United States District Court, N.D. Mississippi, Eastern Division

Date published: Jan 28, 2010

Citations

CIVIL ACTION NO.: 1:10CV3-SA-JAD (N.D. Miss. Jan. 28, 2010)